As we push toward finding cures and less-toxic treatment for children with cancer, we are guided by our CureSearch core values:

HONESTY & INTEGRITY
TRANSPARENCY & ACCOUNTABILITY
CREATIVITY & COLLABORATION

We focus only on children's cancer.		We're not here just to fund research, we're here to drive patient impact.
Our Scientific Advisory Council and Scientific Review Board brain trust is unmatched.	We invest in large-scale grants over a three-year timeframe, which allows our researchers to focus on their work, not fundraising.	We hold ourselves - and our grant recipients - accountable through a novel measurement framework and frequent reporting to our constituents.

We build strong, long-term partnerships with our funded researchers so that successful work is supported beyond the scope of their original CureSearch grant.

We are bridging the 'valley of death' by creating unique partnerships with biotech and pharmaceutical industries to ensure that promising research makes it out of the lab and into the clinic.

This $10M trailblazing initiative is our commitment to surface the most promising children's cancer research, drive it to clinical practice, and quickly find better treatments and cures.

ACCELERATION INITIATIVE 2

In partnership with Rising Tide Foundation for Clinical Cancer Research

$2M over three years
(2015-2018)

International Awards in Pediatric Cancer

AWARD 1: Targeted Research on New Approaches to Childhood Cancer Survivorship

AWARD 2: Targeted Research on Accelerating the Delivery of New Therapies and Clinical Trial Design

Awards will be announced October 2015

Young Investigator grants fund transformational science designed to deliver the next generation of cancer treatment. The program attracts early stage investigators and feeds the pipeline for future AI investigators.

• Acute myeloid leukemia (AML)
• Adolescent and young adult tumors
• Acute lymphoblastic leukemia (ALL)
• Neuroblastoma
• Hodgkin lymphoma
• Rhabdomyosarcoma
• Late effects/survivorship
• Bone, liver, brain and renal tumors

YOUNG INVESTIGATORS

• 
  

  Debanjan Dhar, PhD
  University of California San Diego
  Hepatocellular Carcinoma

• 
  

  David Gordon, MD
  University of Iowa
  Acute Myeloid Leukemia

• 
  

  Eric Raabe, MD, PhD
  Johns Hopkins University
  Pontine Glioma (Brain Cancer)

• 
  

  Shizhen Zhu, MD, PhD
  Mayo Clinic
  Neuroblastoma

YOUNG INVESTIGATOR RESEARCH MILESTONES

YOUNG INVESTIGATOR 2

$1.35M over three years
(2015-2018)*

Encouraged by the promise and success of our first 12 Young Investigators, CureSearch recently awarded six new grants. The new grant term is three years and the award has more than doubled.

• 
  

  Anthony Graves, MD, PhD
  University of Pittsburgh
  Neuroblastoma

• 
  

  Andrew Lee Hong, MD
  Dana Farber Cancer Institute
  Wilms Tumor

• 
  

  Ranjit Bindra, MD, PhD
  Yale University
  Rhabdomyosarcoma

• Abby Rosenberg, MD, MS
  Seattle Children's Hospital
  Palliative Care for AYA
  
  Birgit Knoechel, MD, PhD
  Dana Farber Cancer Institute
  T-cell ALL
  
  Kara Davis, DO
  Stanford University
  BCP-ALL
  

*First progress report expected in November 2015

CureSearch has supported clinical trials in hospitals across the country for many years. In 2014, 55 hospitals received funding to support their pediatric trials. In 2015, we are offering two types of awards for local institutions:

Because soon is not soon enough, CureSearch continues to accelerate the search for new cures. CureSearch bridges the gap between basic research discoveries and getting new cures to kids by:

INVESTING IN HIGH-IMPACT RESEARCH

• 21
  Scientists
• 8
  Potential
  new cures
• 15,780
  Children affected
  each year
  (0-19 years of age)

FOSTERING TRANSFORMATIVE PARTNERSHIPS

• Funding collaborations with other cancer foundations including Rising Tide Foundation for Clinical Cancer Research and Gateway for Cancer Research
• Building partnerships with the pharmaceutical industry
• Facilitating relationships between academic researchers and the pharmaceutical industry partners that can translate new treatments to patient-ready drugs

In addition to driving research to end children's cancer, CureSearch is committed to supporting families and communities facing cancer today.

Eve Griffith Stage V Wilms Tumor Survivor

NEW FOR 2015

Our CureSearch CancerCare
mobile app!

Our work would not be possible without the generous support of thousands of Walkers, Hikers, Challenge-Seekers, and donors.

It is our honor to recognize the following partners for their extraordinary support:

Genentech | Love Your Melon | eBay giving works
Shark Shootout Charities | Anonymous

CureSearch is grateful to the families who have established a Champion or Legacy Fund to honor their child:

• Jacob Koenigs 'Jakefest' Memorial Fund and Kiewit
• Joey Keller Legacy Fund
• Nick Currey Fund
• Amy Miller Champion Fund
• Luke McGuire Legacy Fund
• Danielle's Roses Champion Fund
• Hammond Family Fund
• Eloise Dodge Gould Legacy Fund

The ultimate gift to support children with cancer is a bequest in your final estate plan. CureSearch is honored to be included in the final plans of these extraordinary people:

• Jean B. Michael
• Robert T. Ridley

ULTIMATE GIFTS

You want an end to children's cancer. We do too. Let's work together to raise awareness and the money it takes to find cures. Events are a great way to do both.

CureSearch offers events focused on:

We are shining the spotlight on children's cancer on various social media channels where we post new research developments, stories about members of our CureSearch family, videos, photos and more. Join the conversation: